Mutagenicity of N-oxide Containing Heterocycles and Related Compounds: Experimental and Theoretical Studies

ISSN: 1873-5294 (Online)
ISSN: 1568-0266 (Print)


Volume 14, 24 Issues, 2014


Download PDF Flyer




Current Topics in Medicinal Chemistry

Aims & ScopeAbstracted/Indexed in

Ranking and Category:
  • 11th of 58 in Chemistry, Medicinal



Editor-in-Chief:
Allen B. Reitz
Fox Chase Chemical Diversity Center, Inc
Doylestown, PA
USA


View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 3.453
5 - Year: 3.826

Mutagenicity of N-oxide Containing Heterocycles and Related Compounds: Experimental and Theoretical Studies

Author(s): Martin Gabay, Mauricio Cabrera, Rossanna Di Maio, Juan A. Paez, Nuria Campillo, Maria L. Lavaggi, Hugo Cerecetto and Mercedes González

Affiliation: Grupo de Quimica Medicinal, Facultad de Ciencias, Universidad de la Republica, Igua 4225, 11400 Montevideo, Uruguay.

Abstract

In the development of new drugs, it is very important to know the effects these may bring to those who consume them. Drugs which act upon certain diseases must not cause toxic side effects on healthy organs. These toxic side effects can be quite varied, i.e. mutagenicity, clastogenicity, teratogenicity, etc., but undoubtedly the mutagenicity officiate in the selection process, during preclinical testing, to advance in clinical trials. Mutagenic compounds are removed and cannot continue its development. There are preclinical studies of mutagenicity and genotoxicity, ranging from in vitro to in vivo studies. Particularly, Ames test is recommended by ICH as the first input in these studies. Herein, we investigated the mutagenicity of an in-house chemical library of eighty five N-oxide containing heterocycles using Ames test in Salmonella thyphimurium TA 98 with and without S9 activation and the use of neural networks in order to predict this nondesired activity. N-oxide containing heterocycles are especially relevant regarding its pharmacological activities as antitrypanosoma, anti-leishmania, anti-tuberculosis, anti-cancer, chemopreventive, anti-inflammatory, anti-atherogenic, and analgesic agents. In some cases, a relationship was found between the presence of N-oxide and mutagenicity. Specifically, benzofuroxan system seems to be responsible for the mutagenicity of certain agents against Chagas disease and certain anti-inflammatory agents. However other N-oxides, such as furoxans with anti-inflammatory and anti-atherosclerosis activities, seem to lack mutagenicity. In other cases, such as quinoxaline dioxides with anti-parasitic activity, mutagenicity shows to be substituent dependent. Applying CODES neural network two models were defined, one without metabolism and other with metabolism. These models predict the mutagenicity with and without metabolism in an excellent manner.




Keywords: Ames test, CODES, mutagenicity, neural networks, N-oxides, preclinical tests.

Purchase Online Rights and Permissions

Article Details

Volume: 14
Issue Number: 11
First Page: 1374
Last Page: 1387
Page Count: 14
DOI: 10.2174/1568026614666140506123235
Advertisement

Related Journals




Webmaster Contact: urooj@benthamscience.org Copyright © 2014 Bentham Science